News | Leads Implantable Devices

Data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with non-left bundle branch block (non-LBBB) is limited and when available has been shown to be suboptimal compared to LBBB patients. A new study presented at the 2018 Heart Rhythm Society (HRS) Scientific Sessions, May 9-12 in Boston, compared the effects of targeting the region of increased electrical delay (QLV approach) for left ventricular (LV) lead location to a standard of care (SOC) anatomical implant approach in non-LBBB patients. The comparison was assessed on the Clinical Composite Score (CCS) after 12 months of follow-up.

Home May 18, 2018
Home
News | Heart Failure

In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve exercise tolerance (ET) and quality of life (QoL) for patients with persistent symptomatic heart failure and an ejection fraction between 25 and 45 percent. Results of the prospective FIX-HF-5C Study were presented at the 2018 Heart Rhythm Society (HRS) Scientific Sessions, May 9-12 in Boston.

Home May 18, 2018
Home
A slide image from Reddy's presntation at Heart Rhythm 2018, showing thrombus formation on the face of a Watchman LAA Occluder device in an echo image. #HRS2018
Feature | Left Atrial Appendage (LAA) Occluders

May 18, 2018 — Left atrial appendage closure (LAAC) with the transcatheter Watchman device prevents thromboembolism from ...

Home May 18, 2018
Home
News | Atrial Fibrillation

May 18, 2018 — Catheter ablation for atrial fibrillation (AF) in patients with heart failure in the CASTLE-AF Trial was ...

Home May 18, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

May 18, 2018 — Nearly half of patients prescribed warfarin and just under one third of those using newer direct oral ...

Home May 18, 2018
Home
News | EP Lab

May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have ...

Home May 18, 2018
Home
News | Atrial Fibrillation

May 18, 2018 — Three year results of a study found injection of botulinum toxin into epicardial fat pads in patients ...

Home May 18, 2018
Home
Heart Rhythm Society (HRS) live electrophysiology (EP) procedure case at the 2018 annual meeting. #HRS2018
Feature | HRS | Dave Fornell

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Heart Rhythm Society (HRS) ...

Home May 18, 2018
Home
Atrial fibrillation ablation using the Abbott Ensite electro mapping system. CABANA Trial Confirms Ablation Equal To or Superior to Drug Therapy. #HRS2018
Feature | Atrial Fibrillation

May 16, 2018 – The first results of the randomized, multicenter, long-term, international CABANA clinical trial were ...

Home May 17, 2018
Home
News | EP Lab

May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics as ...

Home May 17, 2018
Home
News

Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during the annual Prague Workshop on Catheter Ablation, April 21-24 in Prague, Czech Republic.

Home May 17, 2018
Home
News | ECG Monitoring Services

A new study published in JAMA Cardiology used the Zio continuous cardiac monitoring system by iRhythm to provide a comprehensive picture of the burden of atrial fibrillation (AF) in patients. Utilizing this data in combination with electronic health record data, the researchers concluded that an increase in AF burden is independently associated with a higher risk of ischemic stroke and arterial thromboembolism in patients who are not taking anticoagulant medication.

Home May 17, 2018
Home
Heart Rhythm Society (HRS) Offers Recommendations to Prepare for Cybersecurity Threats to Cardiac Implantable Devices in new consensus document. #HRS2018
Feature | Cybersecurity

May 16, 2018 — The Heart Rhythm Society (HRS) released communication recommendations to assist healthcare professionals ...

Home May 16, 2018
Home
News | EP Lab

May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced ...

Home May 16, 2018
Home
Technology | Patient Monitors

Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring system to monitor atrial fibrillation (AF) patients’ sleep apnea management status and compliance with continuous positive airway pressure (CPAP) devices on demand.

Home May 16, 2018
Home
Subscribe Now